
Establo Pharma sp. z o.o.
Manufacture of other food products not elsewhere classified
Overview
Financials
Revenue history (in k)
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 76 days for 2021).
- 202517/07/2026
- 202430/06/2025
- 202315/07/2024
- 202228/07/2023
- 202129/09/2022
- 202030/09/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Websites
The company has 12 websites. Most of them run on WordPress. The sites are available in: Polish and English. The sites target these markets: United States. The company measures traffic with Google Analytics and uses the Meta advertising pixel (Facebook, Instagram).
- establopharma.comEstablo Pharma Sp. z o.o.WordPressElementorGoogle AdsGoogle AnalyticsGoogle Tag ManagerLLiteSpeed
- composita.plComposita One i Composita Mama DHA – Wsparcie dla zdrowia kobietWordPress 7.1ElementorGoogle AdsGoogle AnalyticsGoogle Tag ManagerLLiteSpeed
- ellabiom.plEllabiom® – probiotyk i prebiotyk dla kobiet | 11 szczepów bakterii – Ellabiom® to wsparcie mikrobiomu przy infekcjach intymnych, po antybiotykoterapii i w IBS. Probiotyk + prebiotyk w jednej kapsułce. Dla kobiet, które chcą czuć się lepiej.WordPress 7.1ElementorGoogle AnalyticsGoogle Tag ManagerLLiteSpeed
Trademarks
The company holds 9 active trademarks registered with the Polish Patent Office. The first mark was filed in 2014.
| Mark | Protected until | |
|---|---|---|
| Endoprofem | Mar 6, 2033 | |
| inofem Activ | Apr 8, 2029 | |
| inofem Duo | Apr 8, 2029 | |
| DIABEROL CONTROL | Nov 8, 2028 | |
| SUPRAMEN | Nov 8, 2028 |
Job offers
The company currently has 3 active job offers at public employment offices. 5 offers were posted in the last 12 months.
| Position | Gross salary | Added | |
|---|---|---|---|
| Finance and Office Administrator | from 5,000 PLN/month | 20 Oct 2026 | |
| Accountant and Finance and HR Clerk | from 5,400 PLN/month | 19 Oct 2026 | |
| Manual Packer | from 4,806 PLN/month | 7 Oct 2026 |
Authorized Representatives
Manner of representation
The management board represents the company externally and manages its day-to-day operations. Each member of the management board is entitled to represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Michał Jakub Kołodziński age 46 | 18 | $24,311.18 | 36% |
| 18 | $24,311.18 | 36% | |
Others | 14 | $18,908.70 | 28% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2010-10-01.
43 1600 1462 1838 0200 7000 0024
22 1600 1462 1838 0200 7000 0014
60 1600 1462 1838 0200 7000 0009
Debt
No entries in the National Debtors Register (KRZ).
Public aid
28 public aid cases recorded, with a total value of $612,158.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Nov 21, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $6,991$6,991 | Fundusz Wschodni sp. z o.o. | |
| Nov 6, 2025 | Aid for SME participation in trade fairs | $61,426$61,426 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Nov 6, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $41,275$41,275 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2025-11-01 | Developing exports of the Polish INOFEM brand in the Middle East and Asian markets. | $102.7K$102,701 | European Funds for a Modern Economy | |
| 2017-07-01 | Implementation of an internationalisation business model for Establo Pharma Sp. z o.o. in foreign markets. | $102.6K$102,640 | Operational Programme Eastern Poland | |
| 2016-10-14 | Development of a business internationalisation model for ESTABLO PHARMA SP. Z O.O. | $8,886$8,886 | Operational Programme Eastern Poland |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Hemplab sp. z o.o. | $5,520,405.66 | hemplab.pl | ||
| Komarko sp. z o.o. | $4,352,872.40 | komarko.pl | ||
| AG Pharm sp. z o.o. | $3,419,035.23 | agpharm.pl | ||
| CFP Investment sp. z o.o. | $3,299,866.39 | cfp-investment.pl | ||
| Bioticom sp. z o.o. | $2,659,090.32 | bioticom.pl | ||
| Biocorpo sp. z o.o. | $2,454,768.74 | biocorpo.pl | ||
| Noblepharma sp. z o.o. | $1,695,021.71 | noblepharma.pl | ||
| Pharma Dot sp. z o.o. | $1,653,106.12 | pharmadot.pl | ||
| Auralab360 sp. z o.o. | $1,385,659.31 | auralab360.pl | ||
| Bionatur sp. z o.o. + limited partnership | $1,192,779.68 | bionatur.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-02-06 | Address change (Ul. Chemiczna 8 J, 20-329, Lublin → Ul. Tokarska 13, 20-210, Lublin) | |
| 2020-05-18 | Address change (Wojciechowska 9b/9, 20-704, Lublin → Ul. Chemiczna 8 J, 20-329, Lublin) | |
| 2017-09-07 | PKD change (Removed: 12 codes) | |
| 2014-09-23 | Address change (Wojciechowska 5, 20-704, Lublin → Wojciechowska 9b/9, 20-704, Lublin) | |
| 2014-04-15 | Share capital increase (150,000.00 PLN → 250,000.00 PLN) |
FAQ
Last updated: 2026-07-17